GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Innovative Eyewear Inc (NAS:LUCY) » Definitions » EPS (Diluted)

Innovative Eyewear (Innovative Eyewear) EPS (Diluted) : $-0.61 (TTM As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Innovative Eyewear EPS (Diluted)?

Innovative Eyewear's Earnings per Share (Diluted) for the three months ended in Mar. 2024 was $-0.15. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was $-0.61.

Innovative Eyewear's EPS (Basic) for the three months ended in Mar. 2024 was $-0.15. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2024 was $-0.61.

Innovative Eyewear's EPS without NRI for the three months ended in Mar. 2024 was $-0.15. Its EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2024 was $-0.61.

During the past 3 years, the average EPS without NRIGrowth Rate was -91.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 5 years, Innovative Eyewear's highest 3-Year average EPS without NRI Growth Rate was -91.30% per year. The lowest was -264.30% per year. And the median was -177.80% per year.


Innovative Eyewear EPS (Diluted) Historical Data

The historical data trend for Innovative Eyewear's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Innovative Eyewear EPS (Diluted) Chart

Innovative Eyewear Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
EPS (Diluted)
-0.02 -0.11 -0.42 -0.87 -0.63

Innovative Eyewear Quarterly Data
Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.19 -0.15 -0.12 -0.19 -0.15

Competitive Comparison of Innovative Eyewear's EPS (Diluted)

For the Medical Instruments & Supplies subindustry, Innovative Eyewear's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Innovative Eyewear's PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Innovative Eyewear's PE Ratio distribution charts can be found below:

* The bar in red indicates where Innovative Eyewear's PE Ratio falls into.



Innovative Eyewear EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Innovative Eyewear's Diluted EPS for the fiscal year that ended in Dec. 2023 is calculated as

Diluted EPS (A: Dec. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-6.663-0)/10.516
=-0.63

Innovative Eyewear's Diluted EPS for the quarter that ended in Mar. 2024 is calculated as

Diluted EPS (Q: Mar. 2024 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-1.971-0)/12.952
=-0.15

EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.61

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Innovative Eyewear  (NAS:LUCY) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Innovative Eyewear EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Innovative Eyewear's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Innovative Eyewear (Innovative Eyewear) Business Description

Traded in Other Exchanges
N/A
Address
11900 Biscayne Boulevard, Suite 630, North Miami, FL, USA, 33138
Innovative Eyewear Inc is engaged in developing and selling eyeglasses and sunglasses, which are designed to allow customers to remain connected to their digital lives, while also offering prescription eyewear and sun protection. Its products Lucyd Lyte glasses enable the wearer to listen to music, take and make calls, and use voice assistants to perform many common smartphone tasks hands-free.
Executives
Olivia C. Bartlett director 11900 BISCAYNE BLVD., SUITE 630, MIAMI FL 33181
Louis Castro director 11900 BISCAYNE BLVD., SUITE 630, MIAMI FL 33181
Konrad Dabrowski officer: Chief Financial Officer 11900 BISCAYNE BLVD., SUITE 630, MIAMI FL 33181
Kristen Mclaughlin director 11900 BISCAYNE BLVD., SUITE 630, MIAMI FL 33181
Harrison R. Gross director, officer: Chief Executive Officer 11900 BISCAYNE BLVD., SUITE 630, MIAMI FL 33131
Frank Rescigna director 8101 BISCAYNE BLVD., SUITE 705, MIAMI FL 33138
Lucyd Ltd. 10 percent owner 11900 BISCAYNE BLVD., SUITE 630, MIAMI FL 33181
David Eric Cohen officer: Chief Technology Officer 11900 BISCAYNE BLVD., SUITE 705630, MIAMI FL 33131